Ziopharm gets hit with a clinical hold as FDA red lights human study using their fast-built CAR-T
One of Ziopharm’s $ZIO heavily touted, fast-built CAR-Ts isn’t ready for a human trial just yet.
The biotech reports that the FDA has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
